NETWORKING RECEPTION - POSTERS, EXHIBITS AND HUBTALKS
HT-11 - AIM-LO: INSIGHTS ON DYSLIPIDEMIA MANAGEMENT IN CANADIAN CARDIOLOGY CLINICS
Friday, October 24, 2025
5:30pm - 5:50pm ET
Room: Theatre 2
Sponsored By
Join Dr. Michael Heffernan for a Hub Talk session where he will present the latest data from the AIM-LO quality improvement initiative conducted in 112 Canadian cardiology clinics. Explore the clinical characteristics and treatment patterns of patients who don’t achieve LDL-C <1.8mmol/L despite statin use and discover practical strategies to improve LDL-C management and optimize patient outcomes.
Learning Objectives:
At the end of this session participants will be able to:
Examine data from AIM-LO, characterizing patients in secondary prevention who are sub-optimally treated with LLTs according to the 2021 guidelines
Recognize that a scarce minority of patients with LDL-C > 1.8 mmol/L and categorized at high risk of recurrent events are treated with recommended adjunct therapies to statins
Translate AIM-LO findings into actionable strategies for dyslipidemia management in clinical practice
.png)
